The role of age as a comorbidity in idiopathic and connective tissue disease-associated pulmonary arterial hypertension: from the Spanish Registry of Pulmonary Hypertension (REHAP Registry)
Event: ESC Congress 2025
Topic: Epidemiology, Prognosis, Outcome
Session: Phenotyping and risk stratification in pulmonary arterial hypertension
Idiopathic pulmonary arterial hypertension, associated with connective tissue disease and comorbidities: prognostic differences? Results the Spanish Registry of pulmonary hypertension (REHAP Registry)
Event: ESC Congress 2024
Topic: Pulmonary Hypertension
Session: Pulmonary hypertension: insights from registries, retrospective data sets, and meta-analyses
The importance of comorbidities in idiopathic and associated with connective tissue disease pulmonary arterial hypertension: from the Spanish Registry of Pulmonary Hypertension (REHAP Registry)
Event: ESC Congress 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Pulmonary hypertension: insights from registries, retrospective data sets, and meta-analyses
Security of neurohormonal blocking with sacubitril / valsartan, iSGLT2 and mineralocorticoid receptor antagonist in patients with heart failure with reduced eyection fraction and diabetes mellitus
Event: Heart Failure 2019
Topic: Cardiovascular Pharmacotherapy
Session: Pharmacology and Pharmacotherapy
